Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Autoimmune Anemia”

158 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 158 results

Early research (Phase 1)Looking for participantsNCT07083960
What this trial is testing

OM336 in Autoimmune Cytopenias

Who this might be right for
AIHA - Warm Autoimmune Hemolytic AnemiaAIHA - Cold Autoimmune Hemolytic AnemiaITP - Immune Thrombocytopenia
Ouro Medicines 32
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07324889
What this trial is testing

An Open-label, Single-arm, Prospective, Multicenter, Phase I/II Clinical Study on the Safety and Efficacy of CD19/BCMA CAR-T Cell Therapy for Relapsed/Refractory Warm Antibody Autoimmune Hemolytic Anemia

Who this might be right for
Relapsed/Refractory Warm Antibody Autoimmune Hemolytic Anemia
Yihao Wang 24
Not applicableLooking for participantsNCT06312644
What this trial is testing

Study of Ultomiris® (Ravulizumab) Safety in Pregnancy

Who this might be right for
Ultomiris-exposed Pregnant/ PostpartumPregnancyParoxysmal Nocturnal Hemoglobinuria (PNH)+3 more
Alexion Pharmaceuticals, Inc. 75
Large-scale testing (Phase 3)Looking for participantsNCT05057468
What this trial is testing

Second-line Treatment of Primary Autoimmune Hemolytic Anemia

Who this might be right for
Primary Autoimmune Hemolytic Anemia
Assiut University 30
Early research (Phase 1)Looking for participantsNCT06733610
What this trial is testing

CAR T-cell Therapy Targeting CD19 and BCMA in Patients with AIHA Who Have Failed ≥3 Lines of Therapy.

Who this might be right for
Autoimmune Hemolytic AnemiaCD19/BCMA CAR T-cellsUniversal Allogeneic CAR T-cells
Institute of Hematology & Blood Diseases Hospital, China 15
Not applicableTemporarily Not AvailableNCT05221619
What this trial is testing

Post-trial Access for Nipocalimab in Participants With Warm Autoimmune Hemolytic Anemia (wAIHA)

Who this might be right for
Warm Autoimmune Hemolytic Anemia
Janssen Research & Development, LLC
Not applicableLooking for participantsNCT04645199
What this trial is testing

National Longitudinal Cohort of Hematological Diseases

Who this might be right for
Multiple MyelomaAcute Myeloid LeukemiaHemophilia+14 more
Institute of Hematology & Blood Diseases Hospital, China 2,300
Early research (Phase 1)Looking for participantsNCT07075484
What this trial is testing

YTS109 Cell in Subjects With Relapsed/Refractory Autoimmune Hemolytic Anemia

Who this might be right for
Autoimmune Hemolytic Anemia
China Immunotech (Beijing) Biotechnology Co., Ltd. 7
Testing effectiveness (Phase 2)WithdrawnNCT04256148
What this trial is testing

ALXN1830 in Patients With Warm Autoimmune Hemolytic Anemia

Who this might be right for
Warm Autoimmune Hemolytic Anemia
Alexion Pharmaceuticals, Inc.
Very early researchLooking for participantsNCT06653556
What this trial is testing

LCAR-AIO in Subjects With Relapsed/Refractory Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus (SLE)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 34
Post-approval studies (Phase 4)UnknownNCT03918265
What this trial is testing

Tacrolimus Treatment for Refractory Autoimmune Cytopenia

Who this might be right for
Autoimmune Hemolytic AnemiaPure Red Cell AplasiaEvans Syndrome
Peking Union Medical College Hospital 80
Large-scale testing (Phase 3)Study completedNCT00749112
What this trial is testing

Alemtuzumab and Rituximab in the Treatment of Refractory Autoimmune Cytopenias

Who this might be right for
Idiopathic Thrombocytopenic PurpuraAnemia, Hemolytic, Autoimmune
Hospital Universitario Dr. Jose E. Gonzalez 19
Testing effectiveness (Phase 2)Study completedNCT01303952
What this trial is testing

Therapy of Chronic Cold Agglutinin Disease With Eculizumab

Who this might be right for
Cold Agglutinin Disease
University Hospital, Essen 13
Not applicableUnknownNCT05711264
What this trial is testing

Presence of Circulating Cluster of Differentiation 4 Positive 28 Null T Helper Lymphocytes(CD4+CD28-) in Patients With Autoimmune Hemolytic Anemia.

Who this might be right for
Autoimmune Hemolytic Anemia
Assiut University 46
Early research (Phase 1)Study completedNCT04269551
What this trial is testing

A Safety and Tolerability Study of BIVV020 in Adults With Cold Agglutinin Disease

Who this might be right for
Autoimmune Haemolytic Anaemia
Bioverativ, a Sanofi company 12
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07190261
What this trial is testing

A Single-arm Phase 2 Prospective Clinical Study of Enatumab in the Treatment of Relapsed/Refractory Warm Antibody Autoimmune Hemolytic Anemia

Who this might be right for
Autoimmune Hemolytic Anemia
Bing Han 3
Testing effectiveness (Phase 2)Study completedNCT03538041
What this trial is testing

INCB050465 in Participants With Autoimmune Hemolytic Anemia

Who this might be right for
Autoimmune Hemolytic Anemia
Incyte Corporation 25
Large-scale testing (Phase 3)Enrolling By InvitationNCT04138927
What this trial is testing

Open Label Extension Study of Fostamatinib Disodium in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia

Who this might be right for
Warm Antibody Autoimmune Hemolytic Anemia
Rigel Pharmaceuticals 90
Not applicableLooking for participantsNCT01758042
What this trial is testing

Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders

Who this might be right for
Chronic Kidney DiseaseAcute Myeloid Leukemia (AML)Acute Lymphoblastic Leukemia (ALL)+14 more
Massachusetts General Hospital 10
Not applicableLooking for participantsNCT04800458
What this trial is testing

Contribution of Anti-platelet Antibodies Identified With MAIPA Assay in the Demonstration of the Auto-immune Character of a Thrombocytopenia at Diagnosis

Who this might be right for
ThrombocytopeniaImmune ThrombocytopeniaMyelodysplasia
University Hospital, Bordeaux 225
Load More Results